☆ 4.7 Review

BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations

RADIOLOGY (2019)

期刊

RADIOLOGY

卷 291, 期 3, 页码 554-569

出版社

RADIOLOGICAL SOC NORTH AMERICA

DOI: 10.1148/radiol.2019181814

关键词

-

类别

Radiology, Nuclear Medicine & Medical Imaging

向作者/读者索取更多资源

Protocol

Reagent

摘要

Patients who carry the BRCA1 and BRCA2 gene mutations have an underlying genetic predisposition for breast and ovarian cancers. These deleterious genetic mutations are the most common genes implicated in hereditary breast and ovarian cancers. This monograph summarizes the evidence behind current screening recommendations, reviews imaging protocols specific to this patient population, and illustrates some of the imaging nuances of breast and ovarian cancers in this clinical setting. (C) RSNA, 2019

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study

Tamar Safra, Barliz Waissengrin, Deanna Gerber, Rinat Bernstein-Molho, Geula Klorin, Lina Salman, Dana Josephy, Rakefet Chen-Shtoyerman, Ilan Bruchim, Melissa K. Frey, Bhavana Pothuri, Franco Muggia

Summary: The study evaluated the incidence of breast cancer and overall survival in ovarian cancer patients carrying BRCA1/2 mutations. It found that routine breast surveillance may be sufficient in ovarian cancer survivors, as the incidence of breast cancer after ovarian cancer was low in BRCA1/2 mutation carriers.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers

Catherine S. John, Abigail Fong, Rodrigo Alban, Jessica Gillen, Kathleen M. Moore, Christine S. Walsh, Andrew J. Li, B. J. Rimel, Farin Amersi, Ilana Cass

Summary: The study found that 10% of patients with BRCA-associated EOC were diagnosed with BC after EOC, with the majority of BC occurring within three years. Surveillance for BC is recommended for BRCA carriers, and timely genetic testing is imperative for better triaging of BC screening resources and treatment.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Oncology

BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers

Jie Sun, Futao Chu, Jiani Pan, Yaxin Zhang, Lu Yao, Jiuan Chen, Li Hu, Juan Zhang, Ye Xu, Xiaojia Wang, Wenming Cao, Yuntao Xie

Summary: The purpose of this study is to develop a risk prediction model for contralateral breast cancer(CBC) in patients with BRCA1/2 variants. The study found that age, family history, variant location, and endocrine therapy are associated with the risk of CBC. The model provides a useful tool for BRCA1/2 carriers to select risk-reducing strategies based on individual CBC risk.

JOURNAL OF CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers

Maryam Nemati Shafaee, Kristina Goutsouliak, Heather Lin, Therese B. Bevers, Angelica Gutierrez-Barrera, Melissa Bondy, Banu Arun

Summary: This study demonstrates for the first time that aromatase inhibitors reduce the risk of contralateral breast cancer in BRCA mutation carriers. This finding, different from previous studies on tamoxifen, has important clinical implications for chemoprevention.

BREAST CANCER RESEARCH AND TREATMENT (2022)

添加到收藏夹

Article Oncology

Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer

Kadan Yfat, Kotait Mariam, Beiner Mario, Hirte Hal, Josephy Dana, Salman Lina, Bruchim Ilan, Pond Gregory, Helpman Limor

Summary: This study aimed to compare the rates of secondary cytoreduction surgery (SCS) among ovarian cancer patients according to BRCA mutation status. The results showed that patients with germline BRCA mutations were more likely to undergo SCS, possibly due to lower volume disease at recurrence.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Overview on population screening for carriers with germline BRCA mutation in China

Huijun Lei, Min Zhang, Luyao Zhang, Kari Hemminki, Xiao-jia Wang, Tianhui Chen

Summary: Carriers with BRCA1/2 germline pathogenic variants have a high risk of breast and ovarian cancers, among others. The prevalence and spectrum of germline BRCA mutations in the Chinese population show ethnic specificity. Next-generation sequencing panel is the common method for BRCA1/2 screening. It is recommended that all Chinese individuals diagnosed with breast, ovarian, pancreatic, or prostate cancers, as well as healthy family members, undergo BRCA1/2 gene testing to provide risk assessment and timely preventive measures.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Cell Biology

PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

Fengping Shao, Yaoyun Duan, Yunhe Zhao, Yinguang Li, Jun Liu, Cai Zhang, Shanyang He

Summary: PARP inhibitors are beneficial to patients with BRCA mutations, especially for ovarian cancer patients when administered early after diagnosis.

AGING-US (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland

Terhi Aino-Sofia Pallonen, Salla Maria Matleena Lempiainen, Titta Kristiina Joutsiniemi, Riitta Irmeli Aaltonen, Pia Erika Pohjola, Minna Kristiina Kankuri-Tammilehto

Summary: This study analyzed the histopathological, clinical, and genetic characteristics of hereditary breast and ovarian cancer patients in the southwestern Finland population. The results showed that BRCA1 carriers have earlier onset of breast and ovarian cancer compared to BRCA2 carriers. BRCA PV increases the risk of both ovarian and breast cancer. BRCA1 carriers have a higher incidence of triple-negativity, while BRCA2 carriers have a higher risk of bilateral breast cancer. A significant proportion of BRCA1 and BRCA2 families have unique pathogenic variants.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Oncology

Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women

Naela Agha, Bader Alshamsan, Sharifa Al-Farsi, Heba Aly Ateya, Fahad A. Almugbel, Hazem Abdullah Alotaibi, Ayman Omar, Amgad Shahin Mohamed, Hanan Alharthy, Tusneem Elhassan, Hany Salem, Hamed Alhusaini

Summary: This study aims to determine the frequency, pattern, and impact of BRCA gene mutations on patient characteristics and outcomes in Saudi women with ovarian cancer (OC). The study found a higher prevalence of BRCA mutations in Saudi women with OC compared to regional and international figures and observed better clinical outcomes in women with BRCA mutations.

BMC CANCER (2022)

添加到收藏夹

Review Oncology

Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review

D. Huber, S. Seitz, K. Kast, G. Emons, O. Ortmann

Summary: This review analyzed the relationship between HRT use and cancer risk in BRCA mutation carriers. Most studies found no association between HRT and breast cancer risk, but different formulations and duration of use may have an impact on the risk modification.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers

Keren Bahar-Shany, Georgina D. Barnabas, Lisa Deutsch, Netanel Deutsch, Efrat Glick-Saar, Dan Dominissini, Stav Sapoznik, Limor Helpman, Tamar Perri, Anna Blecher, Guy Katz, Itai Yagel, Orgad Rosenblatt, Daniel Shai, Benny Brandt, Raanan Meyer, Aya Mohr-Sasson, Alexander Volodarsky-Perel, Itamar Zilberman, Shunit Armon, Ariella Jakobson-Setton, Ram Eitan, Yfat Kadan, Mario Beiner, Dana Josephy, Malka Brodsky, Eitan Friedman, Liat Anafi, Yossef Molchanov, Jacob Korach, Tamar Geiger, Keren Levanon

Summary: The study aimed to develop a proteomic assay based on proximal liquid biopsy for monitoring high-risk population. The results showed that the assay had high sensitivity and specificity in detecting high-grade ovarian cancer, and the sampling procedure was safe and feasible.

INTERNATIONAL JOURNAL OF CANCER (2023)

添加到收藏夹

Article Oncology

Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy

Sarah Shubeck, Varadan Sevilimedu, Elizabeth Berger, Mark Robson, Alexandra S. Heerdt, Melissa L. Pilewskie

Summary: This study compared the outcomes of BRCA mutation carriers who underwent breast-conserving surgery (BCS) versus mastectomy. The results showed no difference in locoregional recurrence, breast cancer-specific survival, and overall survival between patients who underwent BCS or mastectomy. However, a higher incidence of contralateral breast cancer was observed among patients who underwent unilateral breast surgery.

ANNALS OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review

Serena Bertozzi, Ambrogio P. Londero, Anjeza Xholli, Guglielmo Azioni, Roberta Di Vora, Michele Paudice, Ines Bucimazza, Carla Cedolini, Angelo Cagnacci

Summary: This narrative review examines the role of breast and gynecological risk-reduction surgery in BRCA mutation carriers. It discusses the indications, contraindications, complications, technical aspects, timing, economic impact, ethical issues, and prognostic benefits of the most common prophylactic surgical options. BRCA1/2 mutation carriers have a significantly higher risk of developing breast, ovarian, and serous endometrial cancer. Risk-reducing mastectomy and risk-reducing salpingo-oophorectomy are effective in reducing the risk of breast and ovarian cancer but have side effects such as impact on fertility and early menopause. A multidisciplinary team should inform women considering prophylactic surgery about the implications and hormonal therapies.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Obstetrics & Gynecology

Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers

Tamar Perri, Shani Naor-Revel, Perry Eliassi-Revivo, Dror Lifshitz, Eitan Friedman, Jacob Korach

Summary: The study found no association between fertility treatments and an increased risk of breast cancer in BRCA1/2 mutation carriers. However, an increased breast cancer risk was associated with paternal origin of the mutation and the use of oral contraceptives for more than 5 years.

FERTILITY AND STERILITY (2021)

添加到收藏夹

Article Obstetrics & Gynecology

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines

Liat S. Matan, Tamar Perri, Liron Kogan, Benny Brandt, Raanan Meyer, Gabriel Levin

Summary: Comparing six different hereditary ovarian cancer management guidelines, this study found broad consensus on the limited role of screening for early ovarian cancer detection (4/6) and the recommendation for implementation of Risk-reducing salpingo-oophorectomy (RRSO) (6/6). Variations exist for age at RRSO, and controversy remains regarding fertility issues and hormone replacement therapy recommendations in unaffected young BRCA-mutation carriers following RRSO.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Green Is Rad: Engaging Radiologists in Building More Sustainable Radiology Practices

Priscilla J. Slanetz, Julia H. Schoen, Katherine E. Maturen, Beth Zigmund

JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2023)

添加到收藏夹

Letter Radiology, Nuclear Medicine & Medical Imaging

Radiologists staunchly support patient safety and autonomy, in opposition to the SCOTUS decision to overturn Roe v Wade

Aditya Karandikar, Agnieszka Solberg, Alice Fung, Amie Y. Lee, Amina Farooq, Amy C. Taylor, Amy Oliveira, Anand Narayan, Andi Senter, Aneesa Majid, Angela Tong, Anika L. McGrath, Anjali Malik, Ann Leylek Brown, Anne Roberts, Arthur Fleischer, Beth Vettiyil, Beth Zigmund, Brian Park, Bruce Curran, Cameron Henry, Camilo Jaimes, Cara Connolly, Caroline Robson, Carolyn C. Meltzer, Catherine H. Phillips, Christine Dove, Christine Glastonbury, Christy Pomeranz, Claudia F. E. Kirsch, Constantine M. Burgan, Courtney Scher, Courtney Tomblinson, Cristina Fuss, Cynthia Santillan, Dania Daye, Daniel B. Brown, Daniel J. Young, Daniel Kopans, Daniel Vargas, Dann Martin, David Thompson, David W. Jordan, Deborah Shatzkes, Derek Sun, Domenico Mastrodicasa, Elainea Smith, Elena Korngold, Elizabeth H. Dibble, Elizabeth K. Arleo, Elizabeth M. Hecht, Elizabeth Morris, Elizabeth P. Maltin, Erin A. Cooke, Erin Simon Schwartz, Evan Lehrman, Faezeh Sodagari, Faisal Shah, Florence X. Doo, Francesca Rigiroli, George K. Vilanilam, Gina Landinez, Grace Gwe-Ya Kim, Habib Rahbar, Hailey Choi, Harmanpreet Bandesha, Haydee Ojeda-Fournier, Ichiro Ikuta, Irena Dragojevic, Jamie Lee Twist Schroeder, Jana Ivanidze, Janine T. Katzen, Jason Chiang, Jeffers Nguyen, Jeffrey D. Robinson, Jennifer C. Broder, Jennifer Kemp, Jennifer S. Weaver, Jesse M. Conyers, Jessica B. Robbins, Jessica R. Leschied, Jessica Wen, Jocelyn Park, John Mongan, Jordan Perchik, Jose Pablo Martinez Barbero, Jubin Jacob, Karyn Ledbetter, Katarzyna J. Macura, Katherine E. Maturen, Katherine Frederick-Dyer, Katia Dodelzon, Kayla Cort, Kelly Kisling, Kemi Babagbemi, Kevin C. McGill, Kevin J. Chang, Kimberly Feigin, Kimberly S. Winsor, Kimberly Seifert, Kirang Patel, Kristin K. Porter, Kristin M. Foley, Krupa Patel-Lippmann, Lacey J. McIntosh, Laura Padill, Lauren Groner, Lauren M. Harry, Lauren M. Ladd, Lisa Wang, Lucy B. Spallut, M. Mahesh, M. Victoria Marx, Mark D. Sugi, Marla B. K. Sammer, Maryellen Sun, Matthew J. Barkovich, Matthew J. Miller, Maya Vella, Melissa A. Davis, Meridith J. Englander, Michael Durst, Michael Oumano, Monica J. Wood, Morgan P. McBee, Nancy J. Fischbein, Nataliya Kovalchuk, Neil Lall, Neville Eclov, Nikhil Madhuripan, Nikki S. Ariaratnam, Nina S. Vincoff, Nishita Kothary, Noushin Yahyavi-Firouz-Abadi, Olga R. Brook, Orit A. Glenn, Pamela K. Woodard, Parisa Mazaheri, Patricia Rhyner, Peter R. Eby, Preethi Raghu, Rachel F. Gerson, Rina Patel, Robert L. Gutierrez, Robyn Gebhard, Rochelle F. Andreotti, Rukya Masum, Ryan Woods, Sabala Mandav, Samantha G. Harrington, Samir Parikh, Sammy Chu, Sandeep S. Arora, Sandra M. Meyers, Sanjay Prabhu, Sara Shams, Sarah Pittman, Sejal N. Patel, Shelby Payne, Steven W. Hetts, Tarek A. Hijaz, Teresa Chapman, Thomas W. Loehfelm, Titania Juang, Toshimasa J. Clark, Valeria Potigailo, Vinil Shah, Virginia Planz, Vivek Kalia, Wendy DeMartini, William P. Dillon, Yasha Gupta, Yilun Koethe, Zachary Hartley-Blossom, Zhen Jane Wang, Geraldine McGinty, Adina Haramati, Laveil M. Allen, Pauline Germaine

CLINICAL IMAGING (2023)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

O-RADS MRI After Initial Ultrasound for Adnexal Lesions: AJR Expert Panel Narrative Review

Elizabeth A. Sadowski, Erica B. Stein, Isabelle Thomassin-Naggara, Andrea Rockall, Stephanie Nougaret, Caroline Reinhold, Katherine E. Maturen

Summary: The O-RADS ultrasound and MRI risk stratification systems were developed to aid radiologists in assessing adnexal lesions. Both modalities can accurately characterize benign lesions and provide additional information for further management. MRI plays a crucial role in determining the risk of invasive cancer and guiding personalized treatment options.

AMERICAN JOURNAL OF ROENTGENOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement

Nicole Hindman, Stella Kang, Laure Fournier, Yulia Lakhman, Stephanie Nougaret, Caroline Reinhold, Elizabeth Sadowski, Jian Qun Huang, Susan Ascher

Summary: Laparoscopic myomectomy, a common gynecologic operation, has been regulated since 2014 due to the discovery of a higher prevalence of uterine leiomyosarcoma (LMS). Gynecologic surgeons are in need of an evidence-based, noninvasive evaluation for LMS to avoid the dissemination of aggressive malignant neoplasms.

RADIOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging Care for Transgender and Gender Diverse Patients: Best Practices and Recommendations

Crysta B. Iv Kyrazis, Erica B. Stein, Evelyn F. Carroll, Halley P. Crissman, Daniel L. Kirkpatrick, Ashish P. Wasnik, Vaz Zavaletta, Katherine E. Maturen

Summary: Transgender and gender diverse (TGD) individuals face health disparities and often avoid necessary medical care due to fears of discrimination or mistreatment. The medical community's limited understanding of gender-affirming hormone therapy (GAHT) and gender-affirming surgery further exacerbates disparate care. Specifically in radiology, TGD patients report more negative imaging experiences compared to general health encounters, indicating a need for inclusive imaging care practices. This article highlights opportunities for improvement in radiology departments, including staff education, welcoming environments, trauma-informed care, and appropriate reporting considerations for TGD patients.

RADIOGRAPHICS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Pelvic Recovery After Endometrial Cancer Treatment: Patient-Reported Outcomes and MRI Findings

Katherine E. Maturen, Marisa F. Martin, Christina H. Chapman, Karen McLean, Brandy N. Michaels, Shitanshu Uppal, Joann I. Prisciandaro, Daniela A. Wittmann, Shruti Jolly

Summary: This study investigated the impact of treatment for endometrial cancer on pelvic functional outcomes and sexual function in patients, and found correlations between pathological features and patient-reported outcomes. Patients expressed a clear need for attention to these outcomes during treatment.

ACADEMIC RADIOLOGY (2023)

添加到收藏夹

Letter Radiology, Nuclear Medicine & Medical Imaging

Letter to the Editor: Radiology Action for Climate Change

Jessica R. Leschied, Katherine E. Maturen, Maura Brown, Kate Hanneman, Julia H. Schoen, Beth Zigmund, Benjamin E. Northrup, Jonathan S. Gross, Priya Dave, Sean A. Woolen, Cameron Henry, Cody R. Quirk, Tarek A. Hijaz, Michael E. Zalis, John R. Scheel

ACADEMIC RADIOLOGY (2023)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Adnexal Lesion Imaging: Past, Present, and Future

Elizabeth A. Sadowski, Andrea Rockall, Isabelle Thomassin-Naggara, Lisa M. Barroilhet, Sumer K. Wallace, Priyanka Jha, Akshya Gupta, Atul B. Shinagare, Yang Guo, Caroline Reinhold

Summary: Imaging plays a crucial role in the diagnosis of adnexal lesions, aiding in the determination of lesion nature and potential cancer risk, thereby reducing unnecessary surgical interventions.

RADIOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Public Health Statement of the Association of University Radiologists Committee on Climate Change and Sustainability

Beth Zigmund, Tarek Hijaz, Benjamin E. Northrup, Julia H. Schoen, Kate Hanneman, Maura Brown, Priya Dave, Jonathan S. Gross, Cameron E. Henry, Jessica R. Leschied, Katherine E. Maturen, Cody R. Quirk, Sean A. Woolen, Michael E. Zalis, John R. Scheel

ACADEMIC RADIOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Practical Tips for Reporting Adnexal Lesions Using O-RADS MRI

Krista E. Suarez-Weiss, Elizabeth A. Sadowski, Michelle Zhang, Kristine S. Burk, Vi T. Tran, Atul B. Shinagare

Summary: The Ovarian-Adnexal Reporting and Data System (O-RADS) MRI risk stratification system offers a standardized lexicon and evidence-based risk score for assessing adnexal lesions. Its goals are to enhance report quality and communication between radiologists and clinicians, reduce variability in reporting language, and optimize management of adnexal lesions.

RADIOGRAPHICS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Adnexal Mass Imaging: Contemporary Guidelines for Clinical Practice

Molly E. Roseland, Katherine E. Maturen, Kimberly L. Shampain, Ashish P. Wasnik, Erica B. Stein

RADIOLOGIC CLINICS OF NORTH AMERICA (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Malignant Epithelial Tumors of the Ovary Pathogenesis and Imaging

Katherine E. Maturen, Kimberly L. Shampain, Molly E. Roseland, Michelle D. Sakala, Maggie Zhang, Erica B. Stein

RADIOLOGIC CLINICS OF NORTH AMERICA (2023)

添加到收藏夹

Correction Radiology, Nuclear Medicine & Medical Imaging

O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee (vol 303, pg 35, 2022)

Elizabeth A. Sadowski, Isabelle Thomassin-Naggara, Andrea Rockall, Katherine E. Maturen, Rosemarie Forstner, Priyanka Jha, Stephanie Nougaret, Evan S. Siegelman, Caroline Reinhol

RADIOLOGY (2023)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Gynecologic oncology tumor board: the central role of the radiologist

Hannah S. S. Recht, Kimberly L. L. Shampain, Marta N. N. Flory, Stephanie Nougaret, Emma L. L. Barber, Priyanka Jha, Katherine E. E. Maturen, Elizabeth A. A. Sadowski, Atul B. B. Shinagare, Aradhana M. M. Venkatesan, Jeanne M. M. Horowitz

Summary: This manuscript, written by members of two medical organizations, examines the important role of radiologists in tumor board and outlines the essential imaging findings for management decisions in patients with common gynecologic malignancies, such as ovarian cancer, cervical cancer, and endometrial cancer.

ABDOMINAL RADIOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Distribution of prostate specific membrane antigen (PSMA) on PET-MRI in patients with and without ovarian cancer

Elizabeth A. A. Sadowski, Brittany Lees, Alan B. B. McMillian, Joanna E. E. Kusmirek, Steve Y. Y. Cho, Lisa M. M. Barroilhet

Summary: This study aims to assess the feasibility of PSMA 18F-DCFPyl PET/MR imaging for detecting ovarian cancer and evaluate the PSMA distribution in patients with and without ovarian cancer.

ABDOMINAL RADIOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.